首页 | 本学科首页   官方微博 | 高级检索  
     


Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases
Authors:Fujiwara Atsushi  Kobayashi Hiroyasu  Masuya Masahiro  Maruyama Mitsuko  Nakamura Shiho  Ibata Hidenori  Fujimoto Hajime  Ohnishi Masahiro  Urawa Masahito  Naito Masahiro  Takagi Takehiro  Kobayashi Tetsu  Gabazza Esteban C  Takei Yoshiyuki  Taguchi Osamu
Affiliation:Divisions of Pulmonary and Critical Care Medicine, Mie University School of Medicine, Mie Chuo Medical Center, Tsu, Japan.
Abstract:Background and objective: Interstitial lung diseases (ILD) are characterized by progressive interstitial pulmonary fibrosis and a decline in lung function. Fibrocytes are bone marrow‐derived mesenchymal progenitor cells that may play a role in the pathogenesis of pulmonary fibrosis. Circulating fibrocyte numbers have been correlated with the prognosis of patients with idiopathic pulmonary fibrosis. The aim of the present study was to evaluate the relationship between circulating fibrocytes, and parameters of disease activity and progression in several groups of patients with ILD. Methods: The study population comprised 41 patients with ILD and seven healthy control subjects. Circulating CD45+ collagen‐I+ fibrocytes were evaluated by flow cytometry. Results: The number of circulating fibrocytes was significantly increased in all patients with ILD and particularly in patients with idiopathic interstitial pneumonitis and interstitial pneumonitis associated with collagen vascular disease as compared with healthy control subjects. The numbers of circulating fibrocytes were significantly correlated with pulmonary function test parameters and with serum levels of sialylated carbohydrate antigen, a marker of disease activity. Temporal changes in circulating fibrocyte numbers were evaluated in two patients, and the results suggested that these changes correlated with the activity of ILD. Conclusions: The results from this study provide further evidence for the role of circulating fibrocytes in fibrotic lung diseases.
Keywords:biological marker  chemokine  fibrocyte  interstitial lung disease  lung fibrosis
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号